Efficacy and safety of Nuwiq® (human‐cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2516|24|1|70-76

ISSN： 1351-8216

Source： HAEMOPHILIA, Vol.24, Iss.1, 2018-01, pp. : 70-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A

By  

HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. : 343-350

John Wiley & Sons Inc

Access to resources Recommend Favorite

The use of short‐term central venous catheters for optimizing continuous infusion of coagulation factor concentrate in haemophilia patients undergoing major surgical procedures

By  

HAEMOPHILIA, Vol. 1351-8216, Iss. 5, 2015-09 ,pp. : e364-e368

John Wiley & Sons Inc

Access to resources Recommend Favorite

The use of short‐term central venous catheters for optimizing continuous infusion of coagulation factor concentrate in haemophilia patients undergoing major surgical procedures

By  

HAEMOPHILIA, Vol. 21, Iss. 5, 2015-09 ,pp. : e364-e368

John Wiley & Sons Inc

Access to resources Recommend Favorite

Surgical outcome in patients undergoing reversal of Hartmann's procedures: a multicentre study

By  

COLORECTAL DISEASE, Vol. 17, Iss. 3, 2015-03 ,pp. : 242-249

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight®) in previously treated patients with severe haemophilia A: interim results of the guardian™2 extension trial

By  

HAEMOPHILIA, Vol. 21, Iss. 5, 2015-09 ,pp. : e436-e439

John Wiley & Sons Inc

Access to resources Recommend Favorite